Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scalp cooling effects on paclitaxel pharmacokinetics in advanced breast cancer
NL-OMON20523Active, not recruiting
- Sponsor
- Erasmus MC Cancer Institute
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of paclitaxel in breast cancer (2 arms), sponsored by Erasmus MC Cancer Institute. Started Jan 2016; status: active, not recruiting.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON20523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20523.